Pharma Medica

What Pharma Medica does

Pharma Medica AG is a privately held Swiss pharmaceutical service provider (Pharma-Dienstleister) founded in 2001 and headquartered in Roggwil TG, Switzerland. The company develops, markets, and distributes a portfolio of more than 30 OTC pharmaceutical, dermatological, and dietary-supplement products organized around two proprietary sub-brand families — OCULEA® for dry-eye and ocular surface care, and Ω7 Sanddorn Argousier® / Ω7 Ribes Nigrum® for skin and mucous-membrane health — alongside distributed third-party brands including isla® (throat lozenges), Orthomol (micronutrient supplements), Ortopad® and Ortolux® (eye patches), and, since April 2025, Multi-Gyn®, Multi-Mam®, and Lamisil®.

Core formulations combine natural actives such as ectoin, hyaluronic acid, sea-buckthorn (omega-7) and Sacha Inchi oils, Iceland moss extract, and blackcurrant seed oil, with documented technical differentiators including a 12-hour sustained-release ectoin eye-drop architecture, a hyaluronic-acid / Iceland-moss hydrogel complex with a studied physical barrier against rhinoviruses, and preservative-free, phosphate-free formulations compatible with contact lenses and post-surgical use. The company holds EN ISO 13485 certification for medical-device distribution, audited by MDC GmbH Stuttgart, for over 20 years.

Pharma Medica operates a channel-partner go-to-market: products reach Swiss end-consumers through independent pharmacies (Apotheke), drugstores (Drogerie), opticians, and online pharmacy platforms (e.g., gohealth.ch), supported by an external field sales and training team that delivers B2B training to retail staff. Revenue is generated through wholesale distribution margins on its own branded lines and on distributed third-party brands; pricing is not publicly disclosed. The company has no disclosed external funding and has been self-sustaining for over two decades, employing between 11 and 50 people (CEO Anita Mosimann leads a team spanning marketing, product management, sales and training, customer service, shipping, and scheduling).

Name

Pharma Medica

Legal name

Pharma Medica AG

Website

https://pharmamedica.ch

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

Pharma Medica AG is a Swiss pharmaceutical service provider that develops and distributes OTC eye care, derma, intimate care, throat, and immune-health products through Swiss pharmacies, drugstores, opticians, and online pharmacies.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)

akta.pro industry

PRIMARYHLAIAAAA

Primary Care & General Medicine Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

SECONDARYCRABAAAC

Eye & Lip Skincare

Consumer Products & Retail/Beauty & Personal Care/Skincare

SECONDARYHLAIACAF

Pulmonology & Allergy Specialty Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Specialty Pharmaceuticals

Keywords

• Pharmaceutical distribution
• Eye care products
• Derma cosmetics
• Natural healthcare
• Intimate care products

Headquarters

HQ city

Roggwil

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Marketing or Sales, Supply Chain, Others

Revenue model

1. Proprietary product sales: Pharma Medica AG develops and sells its own branded pharmaceutical and derma products (OCULEA® eye care line, Ω7 Sanddorn Argousier® line, Ortopad® eye patches, Orthomol supplements) through pharmacy, drugstore, optician, and online retail channels. Revenue is generated through wholesale distribution to retail partners and direct-to-consumer online sales.
2. Distribution of third-party brands: Pharma Medica AG acts as a pharmaceutical distribution partner for brands including Multi-Gyn®, Multi-Mam®, Lamisil®, and isla® products (ginger, junior, mousse, cassis). The company takes over distribution responsibilities from previous distributors, generating revenue through distribution margins on branded product sales in the Swiss market.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

Pharma Medica AG is a Swiss pharmaceutical service provider (Pharma-Dienstleister) that develops and distributes its own branded product lines (OCULEA® eye care, Ω7 Sanddorn Argousier® sea buckthorn-based derma/intimate care, Ω7 Ribes Nigrum® black currant skincare, Ortopad® eye patches, Ortolux® sterile eye dressings) alongside third-party brands it distributes in Switzerland (Multi-Gyn®, Multi-Mam®, Lamisil®, isla® throat lozenges, Orthomol, VitroCap®N, ActiProct®). Products are formulated around natural active ingredients (sea buckthorn oil, Sacha Inchi oil, hyaluronic acid, ectoin, Iceland moss extract) and address dry eyes, dry skin, mucous membrane dryness, throat discomfort, and immune support.

Product overview

Pharma Medica AG is a Swiss pharmaceutical distributor operating as a pharma-dienstleister (pharmaceutical service provider) with a portfolio of over 30 products across five health categories. The offering is organized into two sub-brand families — OCULEA® (eye care) and Ω7 Sanddorn Argousier® (sea buckthorn-based dermatology and intimate care) — alongside distributed third-party brands. The OCULEA® line covers the full spectrum of dry eye treatment from basic (OCULEA SOFT) through intensive (OCULEA INTENSE) and allergy-specific (OCULEA ECTOIN) formulations, supplemented by eyelid care (OCULEA LID PLUS), a sea buckthorn spray (OCULEA ARGOUSIER spray), and oral sea buckthorn capsules for eye hydration (OCULEA ARGOUSIER Capsules). The Ω7 Sanddorn Argousier® family provides skin and mucous membrane products including oral capsules, intimate moisturizing cream with applicator, intimate oil-gel, and shower cream, alongside the Ω7 Ribes Nigrum® black currant line for atopic skin (capsules, repair cream, and probiotic skin oil). Additional distributed brands include Orthomol Immun (micronutrients for immune health), Orthomol Cholin Plus (liver/metabolism support), isla® throat lozenges, ActiProct® (hemorrhoid care), and recently acquired Multi-Gyn®, Multi-Mam®, Lamisil®, and VitroCap®N. Eye patch products include Ortopad® branded occlusive patches in themed and neutral variants, and Ortolux® ergonomic shell eye patches.

Differentiator

Problem solved

Functional benefit

Brands

• OCULEA: Natural therapy concept for dry eyes with products for moisturizing, caring, and protecting eyes from inside and outside using natural ingredients like Sacha Inchi or sea buckthorn oil.
• Ω7 Sanddorn Argousier
• Ω7 Ribes Nigrum
• Ortopad

Products and services

• OCULEA® ECTOIN Eye Drops Eye drops for long-lasting relief of allergy symptoms, combining Ectoïne, hyaluronic acid, and carboxymethylcellulose in a cross-linked film that provides up to 12 hours of sustained release on the eye surface. Preservative- and phosphate-free, compatible with contact lenses. For consumers with ocular allergies, dry eyes, and contact lens-related dryness.
• OCULEA® LID PLUS Eyelid Care Wipes Daily eyelid margin care consisting of cotton cleansing wipes impregnated with hyaluronic acid, tea tree oil extract, and aloe vera. Used with a warmed pad to open and cleanse Meibomian glands; indicated for blepharitis, blepharoconjunctivitis, styes, chalazia, and as support for bacterial and allergic conjunctivitis treatment.
• OCULEA® SOFT Eye Drops Basic eye drop product for daily care of dry eyes. Part of the OCULEA® natural therapy concept for ocular hydration, care, and protection using natural ingredients.
• OCULEA® INTENSE Eye Drops Intensive eye drops with high-viscosity 0.3% hyaluronic acid for severe and chronic dry eye. Forms a stable, long-lasting protective film on the cornea; post-surgery compatible, preservative- and phosphate-free; 12-month shelf life after opening.
• OCULEA® PROTECT Night Eye Care Night eye care product for overnight protection and hydration of dry eyes. Supports ocular surface regeneration during sleep.
• OCULEA® SACHA INCHI Eye Drops Eye drops containing high-quality Sacha Inchi seed oil rich in unsaturated fatty acids and vitamin E. Strengthens the lipid phase of the tear film and repairs damage to the ocular surface. Combined with hyaluronic acid, trehalose, and glycerin for high water-retention.
• OCULEA® ARGOUSIER Eye Spray Preservative-free eye spray containing sea buckthorn oil and hyaluronic acid in a microemulsion. Applied on closed eyelids from 15–20 cm to refresh and hydrate tired, dry eyes and surrounding skin; suitable for sensitive eyes, children, contact lens wearers, and makeup users; 6-month shelf life after opening.
• OCULEA® ARGOUSIER Capsules Oral dietary supplement capsules containing sea buckthorn oil for internal hydration and protection of eyes. Includes beta-carotene (vitamin A source) for maintenance of normal vision and vitamin E for cell protection against oxidative stress.
• Ω7 Sanddorn Argousier® Sea Buckthorn Oil Capsules Sea buckthorn (Argousier) oil capsules containing the full spectrum of essential omega fatty acids (3, 6, 7, 9), antioxidants, vitamins, and plant sterols. Available in 60 and 180 capsule packs; suitable for vegetarians, vegans, and fish allergy sufferers. Dosage: 4 capsules daily for 2 weeks, then 2 capsules daily.
• Ω7 Sanddorn Argousier® Intimate Moisturizing Cream Intimate zone moisturizing cream containing sea buckthorn oil, hyaluronic acid, and lactic acid at pH 4.3. Relieves symptoms of vaginal mucosal dryness (during menopause, pregnancy, and breastfeeding). Hypoallergenic, free from colorants, fragrances, parabens, and hormones; includes applicator for internal and external use.
• Ω7 Sanddorn Argousier® Intimate Oil-Gel Sea buckthorn intimate oil-gel for care and protection of skin in the external intimate area. Provides moisture and soothing care with sea buckthorn oil omega fatty acids.
• Ω7 Sanddorn Argousier® Shower Cream Body and intimate area shower cream with sea buckthorn oil (omega-7 and omega-9 fatty acids) and other plant oils. Gently cleanses and moisturizes skin including the intimate area; pH skin-optimal, dermatologically tested; free from mineral oil, parabens, allergenic fragrances, nanoparticles, and sulfates; vegan.
• Ω7 Ribes Nigrum® Black Currant Seed Oil Capsules Black currant seed oil capsules containing omega-3 and omega-6 fatty acids for support of skin and mucous membrane health.
• Ω7 Ribes Nigrum® Repair Cream Black currant oil repair cream with hyaluronic acid and glycerin for atopic and dry skin. Repairs damaged skin, restores skin barrier, soothes itching and redness, hydrates, and prevents inflammation. Contains coconut oil, shea butter, sweet almond oil, and lactic acid. Suitable for children from age 4; cortisone-free and vegan.
• Ω7 Ribes Nigrum® Skin Care Oil with Probiotics Skin care oil with black currant extract and probiotics formulated for atopic and dry skin conditions.
• ActiProct® Hemorrhoid Treatment Product for hemorrhoid treatment and relief of hemorrhoidal symptoms.
• Multi-Gyn® Feminine Intimate Health Distributed brand for women's intimate health and flora balance. Pharma Medica AG took over exclusive Swiss distribution effective April 1, 2025.
• Multi-Mam® Mother & Baby Care Distributed product line for mother and baby intimate health care. Pharma Medica AG took over exclusive Swiss distribution effective April 1, 2025.
• Lamisil® Antifungal Distributed antifungal product for treatment of athlete's foot and skin fungal infections. Pharma Medica AG took over exclusive Swiss distribution effective April 1, 2025.
• VitroCap®N Micronutrient Supplement Selected micronutrients supplement formulated for eye health and support of visual function.
• Orthomol Immun Micronutrient dietary supplement with 22 micronutrients including vitamins A, B6, B12, C, D, folic acid, selenium, iron, copper, and zinc for normal immune system function; also supports normal mucous membranes and protects against oxidative stress. Available in daily portion formats; product has a 30-year track record.
• Orthomol Cholin Plus Natural dietary supplement containing choline and milk thistle (chardon-marie) for liver and metabolism support.
• isla® Junior Strawberry Throat Lozenges Strawberry-flavored throat lozenges formulated for children; also available in a new larger 50-piece packaging format.
• isla® med akut Citrus-Honey Throat Lozenges Throat lozenges with triple action: protection, moisturization, and soothing. Contains a hydrogel complex with hyaluronic acid and Icelandic moss extract; forms a double protective film on irritated mucous membranes. Clinically studied barrier effect against rhinoviruses.
• isla® Mousse, Cassis & Ginger Throat Lozenges Throat lozenges line available in mousse, cassis, and ginger varieties. Provides rapid relief from throat discomfort and hoarseness, durably moisturizes throat mucosa, and promotes regeneration. Ginger variant offers a pleasantly strong flavor beneficial for throat and voice.
• Ortopad® Occlusive Eye Patches Occlusive eye patches for occlusion therapy in children; available in Mix (30 motifs), HAPPY, Boys, Girls (with glitter), and neutral/skin-toned variants. Cotton-based, skin-friendly, ergonomic shape with perforated nose slits, light-blocking, and breathable. Available in junior, medium, and standard sizes.
• Ortolux® Sterile Eye Patch (Uhrglasverband) Sterile, ergonomic eye patch with transparent, break-resistant shell. Suitable for creating a moist chamber in lagophthalmos and after LASIK procedures. Features hypoallergenic, solvent-free HOTMELT pressure-sensitive adhesive; wide visual field; sterile.
• Ortolux® Air Sterile Eye Patch Sterile, ergonomic eye patch with peripheral perforation for comfortable ventilation of the eye without visual field impairment. Particularly suitable for post-operative use after cataract surgery and for mechanical eye protection. 11 mm shell depth; hypoallergenic, solvent-free HOTMELT adhesive; available in two sizes.

Quantifiable outcome

• OCULEA® ECTOIN provides up to 12 hours of sustained symptom relief through ectoin release from a cross-linked film structure on the eye surface
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered core.

• Multi-Gyn® / Multi-Mam® (formerly distributed by KHC)coreChannel Partner/ Reseller/ Distributor · 1 April 2025Pharma Medica AG assumed exclusive distribution rights for the Multi-Gyn® (feminine intimate health) and Multi-Mam® (maternal and baby health) brands in Switzerland effective April 1, 2025, taking over from previous distributor KHC. These brands complement Pharma Medica's existing intimate health portfolio including Ω7 Sanddorn Argousier® products.
• Lamisil® (formerly distributed by KHC)coreChannel Partner/ Reseller/ Distributor · 1 April 2025Pharma Medica AG assumed exclusive distribution rights for Lamisil® (antifungal products for foot and skin mycosis) in Switzerland effective April 1, 2025, expanding the company's dermatology and foot health category. Distribution took over from KHC.
• MDC GmbH Stuttgart (Notified Body)coreOthersMDC GmbH Stuttgart conducted the EN ISO 13485 surveillance audit for Pharma Medica AG's quality management system covering distribution of medical products and accessories. The audit was successfully passed, confirming ongoing certification.

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Galenica AG: Switzerland's largest pharmaceutical retail and wholesale group, operating the Galexis wholesale arm and major pharmacy chains (Amavita, Sun Store). Competes with Pharma Medica for Swiss pharmacy shelf access at much greater scale, and serves as a potential consolidator of mid-sized pharma distributors.
• Alcon Inc. Swiss-headquartered global eye care giant with broad ophthalmic portfolio including Systane® and other dry eye brands. Dominates the same Swiss dry eye category where Pharma Medica's OCULEA® competes, though Alcon operates at vastly greater scale and R&D depth.
• Santen Pharmaceutical Co., Ltd. Japanese-headquartered global ophthalmology company with strong European presence (Santen SAS in France) and portfolio of dry eye and ocular surface disease products. Comparable to Pharma Medica's OCULEA® line for therapeutic focus and pharmacy channel GTM, though at global scale.
• Bausch + Lomb: Global eye health company (Bausch Health subsidiary) with major dry eye, contact lens, and ophthalmic product portfolios competing in the same Swiss eye care OTC space as Pharma Medica's OCULEA® brand, with significantly broader R&D and marketing resources.

Direct peers

• Streuli Pharma AG: Swiss pharmaceutical distributor with own-brand and licensed products in dermatology, OTC, and women's health sold through Swiss pharmacies. Similar business model to Pharma Medica with comparable scale, channel focus, and category breadth.
• Dr. A. & L. Schmidgall GmbH & Co KG: Austrian pharmaceutical manufacturer and distributor with own-brand and licensed pharmaceutical products sold through DACH pharmacy channels. Comparable to Pharma Medica as a mid-sized DACH pharmaceutical service provider combining proprietary and distributed brands.
• Ursapharm Arzneimittel GmbH: German pharmaceutical company specializing in eye care products (HYLO® eye drops line) and distributed through European pharmacy channels. Direct overlap with Pharma Medica's OCULEA® eye care line in terms of product category, formulation philosophy (preservative-free), and pharmacy channel GTM.
• Schwabe Pharma AG: Swiss affiliate of the German Schwabe Group, distributing phytopharmaceutical and natural-origin OTC brands (e.g., Tebonin®, Kytta®) in Switzerland. Highly comparable to Pharma Medica for natural-ingredient OTC positioning, Swiss pharmacy channel, and herbal/botanical formulation philosophy.
• Théa Pharmaceuticals: European ophthalmology company headquartered in Clermont-Ferrand, France, with a strong portfolio of eye drops and dry eye products including natural-origin formulations. Highly comparable to Pharma Medica's OCULEA® line for product type, customer base (European pharmacies), and natural-ingredient positioning.
• Hänseler AG: Swiss pharmaceutical distribution company headquartered in Herisau, offering a portfolio of proprietary and distributed pharmaceutical brands to Swiss pharmacies. Highly comparable to Pharma Medica in business model (Pharma-Dienstleister), scale, channel focus, and product breadth.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/pharmamedicaroggwil
• LinkedInlinkedin.com/company/pharmamedica-ag

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharma Medica